Phase I trial of gemcitabine and capecitabine (xeloda) in patients with advanced pancreatic carcinoma
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2010
At a glance
- Drugs Capecitabine; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
- 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
- 23 Jun 2008 Primary endpoints identified, as reported by ClinicalTrials.gov.